Literature DB >> 23982563

Health-care utilization in Dutch systemic sclerosis patients.

Jessica Meijs1, Elisabeth J M Zirkzee, Anne A Schouffoer, Stella M Henquet, Monique A A Caljouw, Theo Stijnen, Tom W J Huizinga, Annemie J M Schuerwegh, Theodora P M Vliet Vlieland.   

Abstract

This study aims to examine healthcare utilization and its determinants among patients with systemic sclerosis (SSc). A cross-sectional survey among all patients with SSc visiting an outpatient clinic of an academic hospital in the Netherlands was done. Assessments included sociodemographic characteristics and a survey on healthcare utilization including a registration of contacts with healthcare services since onset of disease, contacts, and number of visits with healthcare services over the last 12 months. A total healthcare utilization score of all visits over the last 12 months was computed and classified as high and low care utilization according to the median. In addition, the Short Form-36 and the Scleroderma Health Assessment Questionnaire (SHAQ) were administered. Logistic regression analysis was used to determine the relationship between high and low healthcare utilization as dependent variable and sociodemographic and disease characteristics as independent variables. Sixty-four patients returned the questionnaires. Over the last 12 months, 83% of the patients had had contact with one or more physicians. On average, patients reported 3.9 visits (SD, 2.9) to a rheumatologist and 6.9 visits (SD, 9.3) to other medical specialists over the last 12 months. The median total health-care utilization was six visits over the last 12 months. Multivariate regression showed that a higher SHAQ score was significantly associated with higher health-care utilization. Patients with SSc visited a considerable number of various health-care providers. Patients with more functional disability were using more healthcare.

Entities:  

Mesh:

Year:  2013        PMID: 23982563     DOI: 10.1007/s10067-013-2373-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  24 in total

1.  Scleroderma: health services utilization from patients' perspective.

Authors:  Sindhu R Johnson; Simon Carette; James V Dunne
Journal:  J Rheumatol       Date:  2006-06       Impact factor: 4.666

2.  An empirical comparison of four generic health status measures. The Nottingham Health Profile, the Medical Outcomes Study 36-item Short-Form Health Survey, the COOP/WONCA charts, and the EuroQol instrument.

Authors:  M L Essink-Bot; P F Krabbe; G J Bonsel; N K Aaronson
Journal:  Med Care       Date:  1997-05       Impact factor: 2.983

3.  Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis.

Authors:  P J Nietert; M D Silverstein; R M Silver
Journal:  J Rheumatol       Date:  2001-09       Impact factor: 4.666

4.  Health care usage in Dutch systemic lupus erythematosus patients.

Authors:  E J M Zirkzee; G M Steup-Beekman; A A Schouffoer; S M Henquet; M A A Caljouw; T W J Huizinga; T P M Vliet Vlieland
Journal:  Lupus       Date:  2011-07-18       Impact factor: 2.911

5.  Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample.

Authors:  L Chung; E Krishnan; E F Chakravarty
Journal:  Rheumatology (Oxford)       Date:  2007-11-06       Impact factor: 7.580

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions.

Authors:  Marie Hudson; Brett D Thombs; Russell Steele; Pantelis Panopalis; Evan Newton; Murray Baron
Journal:  J Rheumatol       Date:  2009-02-17       Impact factor: 4.666

8.  Demographic and clinical factors associated with physician service use in systemic sclerosis.

Authors:  Sasha Bernatsky; Pantelis Panopolis; Marie Hudson; Janet Pope; Sharon Leclercq; David Robinson; Niall Jones; Janet Markland; Maysan Abu-Hakima; Jean-Pierre Mathieu; Peter Docherty; Nader Khalidi; Evelyn Sutton; Murray Baron
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

9.  Needs and preferences regarding health care delivery as perceived by patients with systemic sclerosis.

Authors:  Anne A Schouffoer; Elisabeth J M Zirkzee; Stella M Henquet; Monique A A Caljouw; Gerda M Steup-Beekman; Jacob M van Laar; Theodora P M Vliet Vlieland
Journal:  Clin Rheumatol       Date:  2011-01-18       Impact factor: 2.980

10.  Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.

Authors:  Rudolf Mierau; Pia Moinzadeh; Gabriela Riemekasten; Inga Melchers; Michael Meurer; Frank Reichenberger; Michael Buslau; Margitta Worm; Norbert Blank; Rüdiger Hein; Ulf Müller-Ladner; Annegret Kuhn; Cord Sunderkötter; Aaron Juche; Christiane Pfeiffer; Christoph Fiehn; Michael Sticherling; Percy Lehmann; Rudolf Stadler; Eckhard Schulze-Lohoff; Cornelia Seitz; Ivan Foeldvari; Thomas Krieg; Ekkehard Genth; Nicolas Hunzelmann
Journal:  Arthritis Res Ther       Date:  2011-10-21       Impact factor: 5.156

View more
  5 in total

1.  Systemic Sclerosis and Perceptions of Quality in Primary Care.

Authors:  Ashley L Toci; J Madison Hyer; Richard M Silver; Paul J Nietert; Faye N Hant
Journal:  Am J Med Sci       Date:  2016-02-17       Impact factor: 2.378

2.  Quantifying the direct public health care cost of systemic sclerosis: A comprehensive data linkage study.

Authors:  Kathleen Morrisroe; Wendy Stevens; Joanne Sahhar; Gene-Siew Ngian; Candice Rabusa; Nava Ferdowsi; Catherine Hill; Susanna Proudman; Mandana Nikpour
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

3.  How do patients with systemic sclerosis experience currently provided healthcare and how should we measure its quality?

Authors:  Julia Spierings; Cornelia H M van den Ende; Rita M Schriemer; Hein J Bernelot Moens; Egon A van der Bijl; Femke Bonte-Mineur; Marieke P D de Buck; Meeke A E de Kanter; Hanneke K A Knaapen-Hans; Jacob M van Laar; Udo D J Mulder; Judith Potjewijd; Lian A J de Pundert; Thea H M Schoonbrood; Anne A Schouffoer; Alja J Stel; Ward Vercoutere; Alexandre E Voskuyl; Jeska K de Vries-Bouwstra; Madelon C Vonk
Journal:  Rheumatology (Oxford)       Date:  2020-06-01       Impact factor: 7.580

Review 4.  The effect and safety of exercise therapy in patients with systemic sclerosis: a systematic review.

Authors:  Sophie I E Liem; Theodora P M Vliet Vlieland; Jan W Schoones; Jeska K de Vries-Bouwstra
Journal:  Rheumatol Adv Pract       Date:  2019-12-09

5.  Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis.

Authors:  Jessica Meijs; Anne A Schouffoer; Nina Ajmone Marsan; Lucia J M Kroft; Theo Stijnen; Maarten K Ninaber; Tom W J Huizinga; Theodora P M Vliet Vlieland; Jeska K de Vries-Bouwstra
Journal:  RMD Open       Date:  2016-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.